25972770

Haoula Z

2015

Lipidomic analysis of plasma samples from women with polycystic ovary syndrome.

25973451

Moreno LE

2015

Clinical Inquiry: What therapies alleviate symptoms of polycystic ovary syndrome?

25975201

Turkmen S

2016

Roux-en-Y Gastric Bypass Surgery in Patients with Polycystic Ovary Syndrome and Metabolic Syndrome.

25975428

Zhao S

2015

An association study between USP34 and polycystic ovary syndrome.

25978310

Ha L

2015

Association Study between Polycystic Ovarian Syndrome and the Susceptibility Genes Polymorphisms in Hui Chinese Women.

25982422

Santos-Ribeiro S

2015

Ovarian hyperstimulation syndrome after gonadotropin-releasing hormone agonist triggering and freeze-all: in-depth analysis of genetic predisposition.

25982537

Lara LA

2015

Impact of Physical Resistance Training on the Sexual Function of Women with Polycystic Ovary Syndrome.

25982606

Flores-Mart?nez SE

2015

[Association analysis of SNP-63 and indel-19 variant in the calpain-10 gene with polycystic ovary syndrome in women of reproductive age].

25983865

Pistrosch F

2008

New onset of alopecia in a young woman with end-stage renal disease.

25986009

Clements JN

2015

Liraglutide: an injectable option for the management of obesity.

25986306

G?d?c? N

2015

High DHEAS/free testosterone ratio is related to better metabolic parameters in women with PCOS.

25987810

Dennett CC

2015

The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment.

25988879

Tepav?evi? S

2015

Cardiac Nitric Oxide Synthases and Na?/K?-ATPase in the Rat Model of Polycystic Ovary Syndrome Induced by Dihydrotestosterone.

25991051

Jensterle M

2015

Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study.

25993656

Zhang J

2015

High Intake of Energy and Fat in Southwest Chinese Women with PCOS: A Population-Based Case-Control Study.

25993908

Randriamboavonjy V

2015

Metformin reduces hyper-reactivity of platelets from patients with polycystic ovary syndrome by improving mitochondrial integrity.

25994073

Meier JJ

2015

Incretin-based therapies: where will we be 50 years from now?

25994816

Saxena R

2015

Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume.

25994831

Rochlani Y

2015

Metabolic Syndrome: Does it Differ Between Women and Men?

25995732

Ebrahimi-Mamaghani M

2015

Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome.

25999994

Bazarganipour F

2015

The impact of polycystic ovary syndrome on the health-related quality of life: A systematic review and meta-analysis.

25999995

Shahnazi V

2015

Influence of ?-3 fatty acid eicosapentaenoic acid on IGF-1 and COX-2 gene expression in granulosa cells of PCOS women.

25999998

Ghaneei A

2015

Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia.

26000308

Colonese F

2015

The pleiotropic effects of vitamin D in gynaecological and obstetric diseases: an overview on a hot topic.

26000511

Doherty DA

2015

Implications of polycystic ovary syndrome for pregnancy and for the health of offspring.

26001184

Rocca ML

2015

Polycystic ovary syndrome: chemical pharmacotherapy.

26004079

Gabrielli L

2015

Proposed criteria for the identification of polycystic ovary syndrome following menopause: An ancillary study of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).

26004979

Wu H

2015

Metabolic profile of Diane-35 versus Diane-35 plus metformin in Chinese PCOS women under standardized life-style changes.

26010091

Hoang V

2015

Liraglutide improves hypertension and metabolic perturbation in a rat model of polycystic ovarian syndrome.

26010950

Wu B

2015

Evaluation of follicular synchronization caused by estrogen administration and its reproductive outcome.

26017763

Jezovnik MK

2016

Comparison of different methods investigating functional and morphological markers of early atherogenesis in obese women with polycystic ovary syndrome.

26020622

El Dib R

2015

Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance.

26022418

Tar?n JJ

2015

Deficiencies in reporting results of lesbians and gays after donor intrauterine insemination and assisted reproductive technology treatments: a review of the first emerging studies.

26023291

Mansor F

2015

Electrophoretic Techniques for the Detection of Human Microsatellite D19S884.

26024975

Targher G

2016

Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?

26025488

Baquing MA

2015

Spontaneous Ruptured Uterus in an Adolescent With Polycystic Ovarian Syndrome and Endometrial Hyperplasia.

26027246

Sorkina EL

2015

[Familial partial lipodystrophy (Dunnigan syndrome) due to LMNA gene mutation: The first description of its clinical case in Russia].

26029166

Tamagno G

2015

Editorial: neurological and psychiatric disorders in endocrine diseases.

26032655

Jensterle M

2015

Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study.

26032905

Yuan H

2015

Interaction between common variants of FTO and MC4R is associated with risk of PCOS.

26034072

Vryonidou A

2015

MECHANISMS IN ENDOCRINOLOGY: Metabolic syndrome through the female life cycle.

26034121

Tetsi Nomigni M

2015

Steroidogenic enzyme profile in an androgen-secreting adrenocortical oncocytoma associated with hirsustism.

26034812

Scheimann AO

2015

Re: Estrada et al., Children's Hospital Association Consensus Statements for Comorbidities of Childhood Obesity.

26035242

Dabrowski FA

2015

The role of vitamin D in reproductive health--a Trojan Horse or the Golden Fleece?

26036719

Bevilacqua A

2015

Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology--assisted reproduction technology.

26036901

Tal R

2015

The emerging role of angiogenic factor dysregulation in the pathogenesis of polycystic ovarian syndrome.

26036903

Legro RS

2015

Pregnancy in polycystic ovary syndrome I: lessons from a pragmatic explanatory with repository clinical trial.

26037361

Qi Q

2015

[Association of methylenetetrahydrofolate reductase gene polymorphisms with polycystic ovary syndrome].

26039829

Romanowski MD

2015

Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome.

26040477

Yang Q

2015

Association of serum levels of typical organic pollutants with polycystic ovary syndrome (PCOS): a case-control study.

26040479

Walls ML

2015

In vitro maturation is associated with increased early embryo arrest without impairing morphokinetic development of useable embryos progressing to blastocysts.

26040673

Hai L

2015

Infertility in Female Mice with a Gain-of-Function Mutation in the Luteinizing Hormone Receptor Is Due to Irregular Estrous Cyclicity, Anovulation, Hormonal Alterations, and Polycystic Ovaries.

26041153

Chen TS

2015

Effect of Chromium Supplementation on Element Distribution in a Mouse Model of Polycystic Ovary Syndrome.

26045896

Li X

2015

Reversing the reduced level of endometrial GLUT4 expression in polycystic ovary syndrome: a mechanistic study of metformin action.

26047889

Suri JC

2015

Response to Dr Rahul Katyal's commentary.

26048913

Alebi? M?

2015

The phenotypic diversity in per-follicle anti-M?llerian hormone production in polycystic ovary syndrome.

26049638

Obermayer-Pietsch B

2015

Genetics of insulin resistance in polycystic ovary syndrome.

26049937

Aydin Y

2015

What is the Risk of Metabolic Syndrome in Adolescents with Normal BMI who have Polycystic Ovary Syndrome?

26049941

G?m?? ?

2015

Plasma Visfatin Levels in Adolescents with Polycystic Ovary Syndrome: A Prospective Case-Control Study.

26051098

Sarray S

2015

Validity of adiponectin-to-leptin and adiponectin-to-resistin ratios as predictors of polycystic ovary syndrome.

26051101

de Mendon?a-Louzeiro MR

2015

Android fat distribution affects some hemostatic parameters in women with polycystic ovary syndrome compared with healthy control subjects matched for age and body mass index.

26051579

Lai L

2015

Developing clinical practice guidelines for Chinese herbal treatment of polycystic ovary syndrome: A mixed-methods modified Delphi study.

26052744

Ranasinha S

2015

The association between Polycystic Ovary Syndrome (PCOS) and metabolic syndrome: a statistical modelling approach.

26054197

Zheng YH

2015

[Effect of low-frequency electroacupuncture intervention on oxidative stress and glucose metabolism in rats with polycystic ovary syndrome].

26054202

Yang BZ

2015

[Effects of electroacupuncture intervention on changes of quality of ovum and pregnancy out- come in patients with polycystic ovarian syndrome].

26054370

Deligeoroglou EK

2015

Dysfunctional uterine bleeding as an early sign of polycystic ovary syndrome during adolescence.

26054555

Greenwood EA

2015

Putative role for insulin resistance in depression risk in polycystic ovary syndrome.

26057937

Zhao H

2015

Metabolism alteration in follicular niche: The nexus among intermediary metabolism, mitochondrial function, and classic polycystic ovary syndrome.

26058174

?vila-Vergara MA

2015

[Mayer-Rokitansky-K?ster-Hauser syndrome: two cases report].

26059110

Park JH

2015

Study of the association of the T869C polymorphism of the transforming growth factor-?1 gene with polycystic ovary syndrome.

26060208

Naderpoor N

2015

Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.

26061015

He C

2015

Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis.

26061725

Cernea M

2015

Prenatal Testosterone Treatment Leads to Changes in the Morphology of KNDy Neurons, Their Inputs, and Projections to GnRH Cells in Female Sheep.

26062106

Macedo LA

2015

Effects of metformin on the adrenal cortex of androgenized rats.

26062107

Alp E

2015

Nesfatin-1 levels and metabolic markers in polycystic ovary syndrome.

26062206

Li Y

2015

[Professor LAI Xinsheng's treatment experience of infertility by Tongyuan needling technique].

26062522

Triunfo S

2016

Potential impact of maternal vitamin D status on obstetric well-being.

26064969

Kang X

2015

Manifestation of Hyperandrogenism in the Continuous Light Exposure-Induced PCOS Rat Model.

26066290

Hyderali BN

2015

Oxidative stress and cardiovascular complications in polycystic ovarian syndrome.

26066675

Sjaarda LA

2015

Dietary Carbohydrate Intake Does Not Impact Insulin Resistance or Androgens in Healthy, Eumenorrheic Women.

26067083

Albu A

2016

Is prolactin the missing link in adipose tissue dysfunction of polycystic ovary syndrome patients?

26070519

Tso LO

2015

Metformin treatment before and during in vitro fertilization or intracytoplasmic sperm injection in women with polycystic ovary syndrome: summary of a Cochrane review.

26076986

Selen ES

2015

NMR Metabolomics Show Evidence for Mitochondrial Oxidative Stress in a Mouse Model of Polycystic Ovary Syndrome.

26077110

Korkmaz V

2015

Should we change our mind about second trimester biochemical aneuploidy screening markers of patients with polycystic ovary syndrome?

26078189

Ressler IB

2015

Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model.

26081478

Baer TE

2015

Clinical Variability in Cardiovascular Disease Risk Factor Screening and Management in Adolescent and Young Adult Women with Polycystic Ovary Syndrome.

26082286

Falhammar H

2015

Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.

26084427

Marasco LA

2014

Unsolved Mysteries of the Human Mammary Gland: Defining and Redefining the Critical Questions from the Lactation Consultant's Perspective.

26085741

Elfayomy AK

2015

Risk Factors Associated with the Malignant Changes of Symptomatic and Asymptomatic Endometrial Polyps in Premenopausal Women.

26089623

Suresh S

2015

Correlations of Insulin Resistance and Serum Testosterone Levels with LH:FSH Ratio and Oxidative Stress in Women with Functional Ovarian Hyperandrogenism.

26091428

Franks S

2015

Can Animal Models of PCOS Help Point the Way Towards Early and Effective Therapeutic Intervention in Women With the Syndrome?

26093338

Wang W

2015

Detection of urine metabolites in polycystic ovary syndrome by UPLC triple-TOF-MS.

26093541

van Helden J

2015

Performance of the two new fully automated anti-M?llerian hormone immunoassays compared with the clinical standard assay.

26095142

Hukkanen J

2015

The effect of atorvastatin treatment on serum oxysterol concentrations and cytochrome P450 3A4 activity.

26096606

Techatraisak K

2015

No association between CYP17 -34T/C polymorphism and insulin resistance in Thai polycystic ovary syndrome.

26100531

Yilmaz MA

2016

The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome.

26101431

Hecht Baldauff N

2015

Optimal management of polycystic ovary syndrome in adolescence.

26104466

Nascimento JX

2015

Importance of lipid accumulation product index as a marker of CVD risk in PCOS women.

26108912

Zhang Q

2015

Effects of brain-derived neurotrophic factor on oocyte maturation and embryonic development in a rat model of polycystic ovary syndrome.

26114853

Witmer MT

2015

Polycystic Ovary Syndrome and Central Serous Chorioretinopathy.